Literature DB >> 6224687

In vitro activity of norfloxacin against Chlamydia trachomatis.

H Meier-Ewert, G Weil, G Millott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224687     DOI: 10.1007/bf02029532

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  4 in total

1.  Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.

Authors:  M Y Khan; Y Siddiqui; R P Gruninger
Journal:  Antimicrob Agents Chemother       Date:  1981-08       Impact factor: 5.191

2.  Chlamydial infection of the male urethra.

Authors:  J D Oriel; P Reeve; J T Wright; J Owen
Journal:  Br J Vener Dis       Date:  1976-02

3.  In vitro antibacterial activity of AM-715, a new nalidixic acid analog.

Authors:  A Ito; K Hirai; M Inoue; H Koga; S Suzue; T Irikura; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

4.  Comparative in vitro activity of norfloxacin against urinary tract pathogens.

Authors:  D Haase; B Urias; G Harding; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

  4 in total
  8 in total

Review 1.  Antimicrobial chemotherapy of chlamydial infection: where next?

Authors:  G L Ridgway
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

2.  Activity of the newer quinolones against Chlamydia trachomatis.

Authors:  R J Van Roosbroeck; D R Provinciael; D L Van Caekenberghe
Journal:  Br J Vener Dis       Date:  1984-10

3.  In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis.

Authors:  H Meier-Ewert; G Weil; G Millott
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis.

Authors:  W R Bowie; V Willetts; L Sibau
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatis.

Authors:  F W Heessen; H L Muytjens
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

6.  The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.

Authors:  G L Ridgway; G Mumtaz; F G Gabriel; J D Oriel
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

7.  Activities of new quinoline derivatives against genital pathogens.

Authors:  J Aznar; M C Caballero; M C Lozano; C de Miguel; J C Palomares; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

Review 8.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.